| View |
|
DRP-13180
|
Multivitamins + Minerals
|
Powervit
|
|
Capsule
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
PCPR Conversion
|
30 December 2022
|
25 September 2027
|
| View |
|
BR-1435
|
Heparin sodium
|
Ceparin
|
1,000 I.U./mL ( 5,000 I.U./5mL )
|
Solution for Injection (I.V.)
|
ANTITHROMBOTIC AGENT
|
North China Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
05 January 2023
|
19 December 2027
|
| View |
|
DRP-6154
|
Finasteride
|
Finarid
|
5mg
|
Film-Coated Tablet
|
Testosterone-5-Alpha Reductase Inhibitor
|
Unicure Remedies Pvt. Ltd.
|
India
|
Automatic Renewal
|
03 January 2023
|
18 January 2028
|
| View |
|
DRP-13222
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Pitztar
|
4g/500mg
|
Powder for Injection (IV)
|
-
|
Inject Care Parenterals Pvt. Ltd
|
India
|
PCPR Conversion
|
05 January 2023
|
26 March 2025
|
| View |
|
DRP-13223
|
Rabeprazole sodium + Itopride hydrochloride
|
Rabegen
|
20 mg/150mg
|
Modified-Release Capsule
|
-
|
Inventia Healthcare Pvt. Ltd
|
India
|
PCPR Conversion
|
05 January 2023
|
24 November 2026
|
| View |
|
DRP-13221
|
Montelukast (as sodium) + Levocetirizine dihydrochloride
|
Molev
|
10mg/5mg
|
Film- Coated Tablet
|
-
|
Bafna Pharmaceutical Limited
|
India
|
PCPR Conversion
|
05 January 2023
|
03 July 2027
|
| View |
|
DRP-13214
|
Atosiban (as acetate)
|
Evaban
|
7.5 mg/mL (6.75 mg/0.9 mL)
|
Solution for IV Injection
|
-
|
Norris Medicines Limited
|
India
|
PCPR Conversion
|
03 January 2023
|
06 October 2025
|
| View |
|
DRP-13213
|
Ascorbic Acid + Zinc
|
Win-Z Plus
|
100 mg/ 10 mg (equivalent to 27.45 Zinc Sulfate Monohydrate) per 5 mL
|
Syrup (Orange Flavor)
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
PCPR Conversion
|
03 January 2023
|
26 March 2026
|
| View |
|
DRP-13215
|
Telmisartan
|
None
|
80 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
PCPR Conversion
|
03 January 2023
|
09 December 2027
|
| View |
|
DRP-13203
|
Methylprednisolone (As Sodium Succinate)
|
Blodis-40
|
40 mg
|
Lyophilized Powder for Injection (IM/IV)
|
-
|
East African (India) Overseas
|
India
|
Initial
|
28 December 2022
|
28 December 2027
|
| View |
|
DRP-13202
|
Methylprednisolone (As Sodium Succinate)
|
Blodis-1000
|
1 g
|
Lyophilized Powder for Injection (IM/IV)
|
-
|
East African (India) Overseas
|
India
|
Initial
|
28 December 2022
|
28 December 2027
|
| View |
|
DR-XY48528
|
Ascorbic Acid + Zinc
|
Revitazee
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/ 40mg
(equivalent to 110 mg Zinc
Monohydrate)
|
Capsule
|
-
|
Compact Pharmaceuticals, Corp.
|
Philippines
|
Initial (OTC)
|
14 December 2022
|
14 December 2027
|
| View |
|
DRP-11712
|
Medroxyprogesterone Acetate
|
Depo-Queen
|
150 mg/mL
|
Suspension for Injection (IM)
|
-
|
Hansel Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
Initial
|
12 December 2022
|
12 December 2027
|
| View |
|
DR-XY48545
|
Quetiapine (As Fumarate)
|
Victus XR
|
50 mg
|
Sustained Release Tablet
|
-
|
Intas Pharmaceuticals Limited
|
India
|
Initial
|
29 December 2022
|
29 December 2027
|
| View |
|
DR-XY47066
|
Febuxostat
|
Urostar
|
80mg
|
Film-Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Monitored Release (MR)Variation
|
29 December 2022
|
29 December 2027
|
| View |
|
DRP-13109
|
Lynestrenol
|
None
|
0.5mg
|
Tablet
|
-
|
Par Laboratories
|
India
|
Initial
|
01 December 2022
|
01 December 2027
|
| View |
|
DRP-13166
|
Ascorbic Acid + Zinc
|
Apcee Plus
|
500mg/50mg
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
13 December 2022
|
13 December 2027
|
| View |
|
DRP-13186
|
Ascorbic Acid + Zinc
|
Ascorgen Plus
|
500mg/50mg(eq. to 137.25mg Zinc Sulfate monohydrate)
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
16 December 2022
|
16 December 2027
|
| View |
|
DRP-13165
|
Ascorbic Acid
|
Apcee1000
|
1 g
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
13 December 2022
|
13 December 2027
|
| View |
|
DRP-13191
|
Meclizine Hydrochloride
|
Mecligen
|
12.5 mg
|
Chewable Tablet (Orange Flavor)
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial (OTC)
|
22 December 2022
|
22 December 2027
|